Furthermore, in N0 patients with tumor-free LNs according to histopathology (Extended Data Fig. 2a), who are often positive in IC17, detection of MCSP+ DCCs placed patients at high risk for all endpoints (Fig. 2d). The gene discussed is CSPG4; the disease is neoplasm.